RF Acquisition Corp. (NASDAQ:RFAC – Get Free Report) saw a large decrease in short interest in November. As of November 30th, there was short interest totalling 700 shares, a decrease of 22.2% from the November 15th total of 900 shares. Based on an average trading volume of 7,300 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the shares of the company are short sold.
RF Acquisition Stock Performance
RF Acquisition stock remained flat at $11.47 during mid-day trading on Friday. RF Acquisition has a fifty-two week low of $10.68 and a fifty-two week high of $11.47. The stock has a 50 day moving average of $11.37 and a 200-day moving average of $11.22.
Institutional Trading of RF Acquisition
An institutional investor recently raised its position in RF Acquisition stock. Cowen AND Company LLC grew its position in shares of RF Acquisition Corp. (NASDAQ:RFAC – Free Report) by 2.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 157,687 shares of the company’s stock after purchasing an additional 3,637 shares during the period. Cowen AND Company LLC owned approximately 2.71% of RF Acquisition worth $1,742,000 at the end of the most recent reporting period. Institutional investors own 36.55% of the company’s stock.
RF Acquisition Company Profile
RF Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in financial services, media, technology, retail, interpersonal communication, transportation, and education sectors.
Featured Articles
- Five stocks we like better than RF Acquisition
- Quiet Period Expirations Explained
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to Capture the Benefits of Dividend Increases
- Texas Instruments: The Old-School Tech Titan Still Delivering
- 3 Grocery Stocks That Are Proving They Are Still Essential
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for RF Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RF Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.